endocannabinoid CB1 antagonists (University of Sydney)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameendocannabinoid CB1 antagonists (University of Sydney)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Sydney
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Sydney
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A